Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty

Catheterization and Cardiovascular Interventions

Volumn 51, Issue 1, 2000, Pages 42-49

  Hojo, Yukihiro ^a   Ikeda, Uichi ^a   Katsuki, Taka Aki ^a   Mizuno, Osamu ^a   Fukazawa, Hiroshi ^a   Kurosaki, Kenji ^a   Fujikawa, Hideyuki ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary intervention; Endothelium; Restenosis; Vasospasm

Indexed keywords

ANGIOTENSIN; ENDOTHELIN 1; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY SINUS; CORONARY STENT; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN II; ATHERECTOMY, CORONARY; CORONARY VESSELS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; STENTS; THROMBOMODULIN; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 0033858282     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-726X(200009)51:1<42::AID-CCD10>3.0.CO;2-A     Document Type: Article

References (37)

1. Efficacy of adjunctive thrombolytic therapy in percutaneous transluminal coronary angioplasty
2. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: Frequency, prediction, clinical course, management, and follow-up
3. Coronary vasoconstriction routinely occurs after percutaneous transluminal angioplasty
4. Silent myocardial ischemia after coronary angioplasty; distinguishing the shadow from the substance
5. Effect of ramipril, an inhibitor of angiotensin converting enzyme, on the response of the rat thoracic aorta to injury with a balloon catheter
6. Restenosis after percutaneous transluminal coronary angioplasty: A report from the PTCA registry of the National Heart, Lung, and Blood Institute
7. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients
8. Restenosis after coronary angioplasty: Pathogenesis of neointimal thickening initiated by endothelial loss
9. A cascade model for restenosis: A special case of atherosclerosis progression
10. Cultured bovine endothelial cells produce both urokinase and tissue plasminogen activators
11. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells
12. Identification of an endothelial cell surface cofactor for thrombin-catalyzed activation of protein C
13. The role of protein C and thrombomodulin in the regulation of blood coagulation
14. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernatants of cultured human umbilical vein endothelial cells
15. Role of endothelium in response of vascular smooth muscle
16. Endothelium-dependent vascular responses, mediators and mechanisms
17. Regulatory functions of the vascular endothelium
18. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
19. Abnormalities of factor VIII and platelet aggregation: Use of ristocetin in diagnosing the von Willebrand syndrome
20. Circulating immunoreactive endothelin in patients undergoing percutaneous transtuminal coronary angioplasty
21. Effect of percutaneous transluminal coronary angioplasty on circulating endothelin levels
22. Release of immunoreactive endothelin from the heart during percutaneous transluminal coronary angioplasty
23. Endothelin-1 in patients with coronary heart disease undergoing cardiac catheterization
24. Influence of percutaneous transluminal coronary angioplasty on cardiac release of endothelin, neuropeptide Y and noradrenaline
25. Local changes in the plasma endothelin level in the coronary artery immediately after percutaneous transluminal coronary angioplasty
26. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo
27. Cardiac release and kinetics of endothelin after umcomplicated percutaneous transluminal coronary angioplasty
28. Endothelin modulates vascular smooth muscle structure and vasomotion: Implications in cardiovascular pathology
29. 125I]endothelin-1 binding data
30. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells
31. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
32. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
33. Neointima formation after vascular injury is angiotensin II mediated
34. Endothelin-1 and angiotensin II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: Evidence for common signaling mechanisms
35. Von Willebrand factor: A marker of endothelial damage
36. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
37. Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidemia